Regulation of myocardial triacylglycerol synthesis and metabolism

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1634, Issue 3, 2003, Pages 63-75

  Lewin, Tal M ^a   Coleman, Rosalind A ^a  

^a University of North Carolina   (United States)

Author keywords

Fatty acid uptake; Heart; Lipolysis; Lipoprotein; Triacylglycerol synthesis

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; CD36 ANTIGEN; CHYLOMICRON; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; FATTY ACID BINDING PROTEIN; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; N ETHYLMALEIMIDE; PHOSPHATIDATE PHOSPHATASE; PHOSPHOLIPID; PROTEIN; STREPTOZOCIN; TRANSFERASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

APOPTOSIS; CORRELATION ANALYSIS; ENZYME SYNTHESIS; FATTY ACID TRANSPORT; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; LIPOPROTEIN SECRETION; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; REVIEW;

EID: 0345708433     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2003.09.006     Document Type: Review

References (136)

1. Grynberg A., Demaison L. Fatty acid oxidation in the heart. J. Cardiovasc. Pharmacol. 28(suppl. 1):1996;S11-S17.
2. Saddik M., Lopaschuk G.D. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem. 266:1991;8162-8170.
3. Jacob S. Lipid droplet accumulation in the heart during fasting. Acta Histochem. 82:1987;149-152.
4. Adams M.G., Barer R., Joseph S., Om'Iniabohs F. Fat accumulation in the rat heart during fasting. J. Pathol. 135:1981;111-126.
5. van den Berghe G. The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. J. Inherit. Metab. Dis. 14:1991;407-420.
6. Stanley W.C., Lopaschuk G.D., McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res. 34:1997;25-33.
7. Zhou Y.-T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. 97:2000;1784-1789.
8. Suzuki J., Shen W.J., Nelson B.D., Selwood S.P., Murphy G.M. Jr., Kanehara H., Takahashi S., Oida K., Miyamori I., Kraemer F.B., Kanefara H. Cardiac gene expression profile and lipid accumulation in response to starvation. Am. J. Physiol: Endocrinol. Metab. 283:2002;E94-E102.
9. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., Han X., Gross R.W., Kozak R., Lopaschuk G.D., Kelly D.P. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109:2002;121-130.
10. Chiu H.-C., Kovacs A., Ford D.A., Hsu F.-F., Garcia R., Herrero P., Saffitz J.E., Schaffer J.E. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107:2001;813-822.
11. Boren J., Veniant M.M., Young S.G. Apo B100-containing lipoproteins are secreted by the heart. J. Clin. Invest. 101:1998;1197-1202.
12. Bjorkegren J., Veniant M., Kim S.K., Withycombe S.K., Wood P.A., Hellerstein M.K., Neese R.A., Young S.G. Lipoprotein secretion and triglyceride stores in the heart. J. Biol. Chem. 276:2001;38511-38517.
13. Nielsen L.B., Bartels E.D., Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J. Biol. Chem. 277:2002;27014-27020.
14. Schoonderwoerd K., von der Kraaij T., Hulsmann W.C., Stam H. Hormones and triacylglycerol metabolism under normoxic and ischemic conditions. Mol. Cell. Biochem. 88:1989;129-137.
15. Stam H., Schoondewoerd K., Hulsmann W.C. Synthesis, storage and degradation of myocardial triglycerides. Basic Res. Cardiol. 82:1987;19-28.
16. Brinkmann J.F.F., Abumrad N.A., Ibrahimi A., van der Vusse G.J., Glatz J.F.C. New insights into long-chain fatty acid uptake by heart muscle: a crucial role for fatty acid translocase/CD36. Biochem. J. 367:2002;561-570.
17. van der Vusse G.J., van Bilsen M., Glatz J.F.C. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc. Res. 45:2000;279-293.
18. Merkel M., Eckel R.H., Goldberg I.J. Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 43:2002;1997-2006.
19. Hauton D., Bennett M.J., Evans R.D. Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference. Biochim. Biophys. Acta. 1533:2001;99-109.
20. Augustus A.S., Kako Y., Yagyu H., Goldberg I.J. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am. J. Physiol: Endocrinol. Metab. 284:2003;E331-E339.
21. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37:1996;693-707.
22. Xiang S.Q., Cianflone K., Kalant D., Sniderman A.D. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. J. Lipid Res. 40:1999;1655-1663.
23. O'Brien K.D., Ferguson M., Gordon D., Deeb S.S., Chait A. Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler. Thromb. 14:1994;1445-1451.
24. Doolittle M.H., Ben-Zeev O., Elovson J., Martin D., Kirchgessner T.G. The response of lipoprotein lipase to feeding and fasting: evidence for post-translational regulation. J. Biol. Chem. 265:1990;4570-4577.
25. Sambandam N., Abrahani M.A., Craig S., Al-Atar O., Jeon E., Rodrigues B. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts. Am. J. Physiol, Heart Circ. Physiol. 278:2000;H1874-H1882.
26. Neitzel A.S., Carley A.N., Severson D.L. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice. Am. J. Physiol: Endocrinol. Metab. 284:2003;E357-E365.
27. Yagyu H., Chen G., Yokoyama M., Hirata K., Augustus A., Kako Y., Seo T., Hu Y., Lutz E.P., Merkel M., Bensadoun A., Homma S., Goldberg I.J. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111:2003;419-426.
28. Binas B., Danneberg H., McWhir J., Mullins L., Clark A.J. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. Faseb J. 13:1999;805-812.
29. Stump D.D., Zhou S.L., Berk P.D. Comparison of plasma membrane FABP and mitochondrial isoform of aspartate aminotransferase from rat liver. Am. J. Physiol. 265:1993;G894-G902.
30. Stremmel W., Strohmeyer G.B.F., Kochwa S., Berk P.D. Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 82:1985;4-8.
31. Luiken J.J.F.P., Turcotte L., Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J. Lipid Res. 40:1999;1007-1016.
32. Luiken J.J., Arumugam Y., Dyck D.J., Bell R.C., Pelsers M.M., Turcotte L.P., Tandon N.N., Glatz J.F., Bonen A. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 276:2001;40567-40573.
33. Luiken J.J.F.P., Arumugam Y., Bell R.C., Calles-Escandon J., Tandon N.N., Glatz J.F.C., Bonen A. Changes in fatty acid transport and transporters are related to the severity of insulin deficiency. Am. J. Physiol: Endocrinol. Metab. 283:2002;E62-E621.
34. Tanaka T., Kawamura K. Isolation of myocardial membrane long-chain fatty acid-binding protein: homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J. Mol. Cell. Cardiol. 27:1995;1613-1622.
35. Coort S.L.M., Willems J., Coumans W.A., van der Vusse G.J., Bonen A., Glatz J.F.C., Luiken J.J.F.P. Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol. Cell. Biochem. 239:2002;213-219.
36. Ibrahimi A., Sfeir Z., Magharaie H., Amri E.-Z., Grimaldi P., Abumrad N.A. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2646-2651.
37. van Nieuwenhoven F.A., Luiken J.J.F.P., de Jong Y.F., Grimaldi P.A., van der Vusse G.J., Glatz J.F.C. Stable transfection of fatty acid translocase (CD36) in a rat heart muscle cell line (H9c2). J. Lipid Res. 39:1998;2039-2047.
38. Tanaka T., Kawamura K. Isolation of long chain fatty acid-binding protein: homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J. Mol. Cell. Cardiol. 27:1995;1613-1622.
39. Coburn C.T., Knapp F.F., Febbraio M., Beets A.L., Silverstein R.L., Abumrad N.A. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 42:2000;32523-32529.
40. Bell R.M., Coleman R.A. Enzymes of triacylglycerol formation in mammals. Boyer P.D. The Enzymes. vol. XVI:1983;87-112 Academic Press, New York.
41. Hahn R.T., Febbraio M., Bella J.N., Silverstein R.L. The role of CD36 in cardiac size and function: a possible murine model of dilated cardiomyopathy. Circulation. 9:1998;I1236.
42. Irie H., Krukenkamp I.B., Brinkmann J.F., Gaudette G.R., Saltman A.E., Jou W., Glatz J.F., Abumrad N.A., Ibrahimi A. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc. Natl. Acad. Sci. U. S. A. 100:2003;6819-6824.
43. Aitman T.J., Glazier A.M., Wallace C.A., Cooper L.D., Norsworthy P.J., Wahid F.N., Al-Majali K.M., Trembling P.M., Mann C.J., Shoulders C.C., Graf D., St Lezin E., Kurtz T.W., Kren V., Pravenec M., Ibrahimi A., Abumrad N.A., Stanton L.W., Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet. 21:1999;76-83.
44. Hajri T., Ibrahimi A., Coburn C.T., Knapp F.F., Kurtz T., Pravenec M., Abumrad N.A. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J. Biol. Chem. 276:2001;23661-23666.
45. Kusaka Y., Tanaka T., Okamoto F., Terasaki F., Matsunaga Y., Miyazaki H., Kawamura K. Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy. J. Mol. Cell. Cardiol. 27:1995;1605-1612.
46. Tanaka T., Nakata T., Oka T., Ogawa T., Okamoto F., Kusaka Y., Sohmiya K., Shimamoto K., Itakura K. Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. J. Lipid Res. 42:2001;751-759.
47. Van Nieuwenhoven F.A., Verstijnen C.P., Abumrad N.A., Willemsen P.H., Van Eys G.J., Van der Vusse G.J., Glatz J.F. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem. Biophys. Res. Commun. 207:1995;747-752.
48. Pelsers M.M., Lutgerink J.T., Nieuwenhoven F.A., Tandon N.N., van der Vusse G.J., Arends J.W., Hoogenboom H.R., Glatz J.F. A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes. Biochem. J. 337(Pt 3):1999;407-414.
49. Van der Lee K.A., Willemsen P.H., Samec S., Seydoux J., Dulloo A.G., Pelsers M.M., Glatz J.F., Van der Vusse G.J., Van Bilsen M. Fasting-induced changes in the expression of genes controlling substrate metabolism in the rat heart. J. Lipid Res. 42:2001;1752-1758.
50. Greenwalt D.E., Scheck S.H., Rhinehart-Jones T. Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet. J. Clin. Invest. 96:1995;1382-1388.
51. Sfeir Z., Ibrahimi A., Amri E., Grimaldi P., Abumrad N. Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot. Essent. Fat. Acids. 57:1997;17-21.
52. Leone T.C., Weinheimer C.J., Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7473-7478.
53. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273:1998;5678-5684.
54. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., Kelly D.P. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1226-1231.
55. Griffin E., Re A., Hamel N., Fu C., Bush H., McCaffrey T., Asch A.S. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat. Med. 7:2001;840-846.
56. Young M.E., Guthrie P.H., Razeghi P., Leighton B., Abbasi S., Patil S., Youker K.A., Taegtmeyer H. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes. 51:2002;2587-2595.
57. Zou Z., DiRusso C.C., Ctrnacta V., Black P.N. Fatty acid transport in Saccharomyces cerevisiae. Directed mutagenesis of FAT1 distinguishes the biochemical activities associated with Fat1p. J. Biol. Chem. 277:2002;31062-31071.
58. Zou Z., Tong F., Faergeman N.J., Borsting C., Black P.N., DiRusso C.C. Vectorial acylation in Saccharomyces cerevisiae. Fat1p and fatty acyl-CoA synthetase are interacting components of a fatty acid import complex. J. Biol. Chem. 278:2003;16414-16422.
59. Klein K., Steinberg R., Fiethen B., Overath P. Fatty acid degradation in Escherichia coli. An inducible system for the uptake of fatty acids and further characterization of old mutants. Eur. J. Biochem. 19:1971;442-450.
60. Frerman F.E., Bennett W. Studies on the uptake of fatty acids by Escherichia coli. Arch. Biochem. Biophys. 159:1973;434-443.
61. Azizan A., Sherin D., DiRusso C.C., Black P.N. Energetics underlying the process of long-chain fatty acid transport. Arch. Biochem. Biophys. 365:1999;299-306.
62. DiRusso C.C., Black P.N. Long-chain fatty acid transport in bacteria and yeast. Paradigms for defining the mechanism underlying this protein-mediated process. Mol. Cell. Biochem. 192:1999;41-52.
63. Kennedy E.P. Biosynthesis of complex lipids. Fed. Proc. 20:1961;934-940.
64. Coleman R.A., Lewin T.M., Muoio D.M. Physiological and nutritional regulation of enzymes of triacylglycerol synthesis. Annu. Rev. Nutr. 20:2000;77-103.
65. Coleman R.A., Van Horn C.G., Gonzalez-Baro M.R., Lewin T.M. Long-chain acyl-CoA synthetase isoforms and their functions. Haldar D., Das S.K. LIPIDS: Glycerolipid Metabolizing Enzymes. vol. 37:2002;1-15 Research Signpost, Kerala, India.
66. Coleman R.A., Lewin T.M., Van Horn C.G., Gonzalez-Baro M.R. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 132:2002;2123-2126.
67. Suzuki H., Kawarabayasi Y., Kondo J., Abe T., Nishikawa K., Kimura S., Hashimoto T., Yamamoto T. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 265:1990;8681-8685.
68. Fujino T., Yamamoto T. Cloning and functional expression of a novel long-chain acyl-CoA synthetase expressed in brain. J. Biochem. 111:1992;197-203.
69. Fujino T., Kang M.-J., Suzuki H., Iijima H., Yamamoto T. Molecular characterization and expression of rat acyl-CoA synthetase 3. J. Biol. Chem. 271:1996;16748-16752.
70. Normann P.T., Norseth J., Flatmark T. Acyl-CoA synthetase activity of rat heart mitochondria. Substrate specificity with special reference to very-long-chain and isomeric fatty acids. Biochim. Biophys. Acta. 752:1983;474-481.
71. Kim J.-H., Lewin T.M., Coleman R.A. Selective inhibition of recombinant rat acyl-CoA synthetases 1, 4, and 5 by triacsin C and thiazolidinediones. J. Biol. Chem. 276:2001;24667-24673.
72. Muoio D.M., Lewin T.M., Weidmar P., Coleman R.A. Acyl-CoAs are functionally channeled in liver: potential role of acyl-CoA synthetase. Am. J. Physiol. 279:2000;E1366-E1373.
73. Lewin T.M., Kim J.-H., Granger D.A., Vance J.E., Coleman R.A. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 276:2001;24674-24679.
74. Martin G., Schoonjans K., Lefebvre A.M., Staels B., Auwerx J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators. J. Biol. Chem. 272:1997;28210-28217.
75. Shimomura I., Tokunaga K., Jiao S., Funahashi T., Keno Y., Kobatake T., Kotani K., Suzuki H., Yamamoto T., Tarui S., Matsuzawa Y. Marked enhancement of acyl-CoA synthetase activity and RNA, paralleled to lipoprotein lipase mRNA, in adipose tissues of Zucker obese rats (fa/fa). Biochim. Biophys. Acta. 1124:1992;112-118.
76. Schaffer J.E., Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell. 79:1994;427-436.
77. Herrmann T., Buchkremer F., Gosch I., Hall A.M., Bernlohr D.A., Stremmel W. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene. 270:2001;31-40.
78. Coe N.R., Smith A.J., Frohnert B.I., Watkins P.A., Bernlohr D.A. The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase. J. Biol. Chem. 274:1999;36300-36304.
79. Hirsch D., Stahl A., Lodish H.F. A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8625-8629.
80. Gimeno R.E., Ortegon A.M., Patel S., Punreddy S., Ge P., Sun Y., Lodish H.F., Stahl A. Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem. 2003;. (e-pub M211412200).
81. Pohl J., Fitscher B.A., Ring A., Ihl-Vahl R., Strasser R.H., Stremmel W. Fatty acid transporters in plasma membranes of cardiomyocytes in patients with dilated cardiomyopathy. Eur. J. Med. Res. 5:2000;438-442.
82. Swanton E.M., Saggerson E.D. Glycerolipid metabolizing enzymes in rat ventricle and in cardiac myocytes. Biochim. Biophys. Acta. 1346:1997;93-102.
83. Lewin T.M., Granger D.A., Kim J.H., Coleman R.A. Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discrdant with protein expression. Arch. Biochem. Biophys. 396:2001;119-127.
84. Yet S.-F., Lee S., Hahm Y.T., Sul H.S. Expression and identification of p90 as the murine mitochondrial glycerol-3-phosphate acyltransferase. Biochemistry. 32:1993;9486-9491.
85. Bhat B.G., Wang P., Kim J.-H., Black T.M., Lewin T.M., Fiedorek T.F., Coleman R.A. Rat hepatic sn-glycerol-3-phosphate acyltransferase: molecular cloning and characterization of the cDNA and expressed protein. Biochim. Biophys. Acta. 1439:1999;415-423.
86. Saggerson E.D., Carpenter C.A. Effects of streptozotocin-diabetes and insulin administration in vivo or in vitro on the activities of five enzymes in the adipose-tissue triacylglycerol-synthesis pathway. Biochem. J. 243:1987;289-292.
87. Shin D.-H., Paulauskis J.D., Moustaid N., Sul H.S. Transcriptional regulation of p90 with sequence homology to Escherichia coli glycerol-3-phosphate acyltransferase. J. Biol. Chem. 266:1991;23834-23839.
88. Igal R.A., Wang S., Gonzales-Baro M., Coleman R.A. Mitochondrial glycerol phosphate acyltransferase directs incorporation of exogenous fatty acids into triacylglycerol. J. Biol. Chem. 276:2001;42205-42212.
89. Hammond L.E., Gallagher P.A., Wang S., Hiller S., Kluckman K.D., Posey-Marcos E.L., Maeda N., Coleman R.A. Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol. Cell. Biol. 22:2002;8204-8214.
90. West J., Tompkins C.K., Balantac N., Nudelman E., Meengs B., White T., Bursten S., Coleman J., Kumar A., Singer J.W., Leung D.W. Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells. DNA Cell Biol. 16:1997;691-701.
91. Agarwal A.K., Arioglu E., De Almeida S., Akkoc N., Taylor S.I., Bowcock A.M., Barnes R.I., Garg A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31:2002;21-23.
92. Ruan H., Pownall H.J. Overexpression of 1-acyl-glycerol-3-phosphate acyltransferase-alpha enhances lipid storage in cellular models of adipose tissue and skeletal muscle. Diabetes. 50:2001;233-240.
93. Brindley D.N., Waggoner D.W. Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem. 273:1998;24281-24284.
94. Schoonderwoerd K., Broekhoven-Schokker S., Hulsmann W.C., Stam H. Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in isolated rat heart. Biochem. J. 268:1990;487-492.
95. Murphy E., Freudenrich C.C., Lieberman M. Cellular magnesium and Na/Mg exchange in heart cells. Annu. Rev. Physiol. 53:1991;273-287.
96. Murphy E., Steenbergen C., Levy L.A., Raju B., London R.E. Cytosolic free magnesium levels in ischemic rat heart. J. Biol. Chem. 264:1989;5622-5627.
97. Kirkels J.H., van Echteld C.J., Ruigrok T.J. Intracellular magnesium during myocardial ischemia and reperfusion: possible consequences for postischemic recovery. J. Mol. Cell. Cardiol. 21:1989;1209-1218.
98. Cases S., Smith S.J., Zheng Y.-W., Myers H.M., Lear S.R., Sande E., Novak S., Collins C., Welch C.B., Lusis A.J., Erickson S.K., Farese R.V. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13018-13023.
99. Cases S., Stone S.J., Zhou P., Yen E., Tow B., Lardizabal K.D., Voelker T., Farese R.V. Jr. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276:2001;38870- 38876.
100. Stals H.K., Mannaerts G.P., Declercq P.E. Factors influencing triacylglycerol synthesis in permeabilized rat hepatocytes. Biochem. J. 283:1992;719-725.
101. Stals H.K., Top W., Declercq P.E. Regulation of triacylglycerol synthesis in permeabilized rat hepatocytes: role of fatty acid concentration and diacylglycerol acyltransferase. FEBS Lett. 343:1994;99-102.
102. Meegalla R.L., Billheimer J.T., Cheng D. Concerted elevation of acyl-coenzyme A:diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem. Biophys. Res. Commun. 298:2002;317-323.
103. Swanton E.M., Saggerson E.D. Effects of adrenaline on triacylglycerol synthesis and turnover in ventricular myocytes from adult rats. Biochem. J. 328:1997;913-922.
104. Wong J.T., Man R.Y., Choy P.C. The effects of lidocaine and hypoxia on phospholipid biosynthesis in the isolated hamster heart. Lipids. 31:1996;1059-1067.
105. Fotheringham J., Xu F.Y., Nemer M., Kardami E., Choy P.C., Hatch G.M. Lysophosphatidylethanolamine acyltansferase activity is elevated during cardiac cell differentiation. Bichim. Biophys. Acta. 1485:2000;1-10.
106. Lee D.P., Deonarine A.S., Kienetz M., Zhu Q., Skrzypczak M., Chan M., Choy P.C. A novel pathway for lipid biosynthesis: the direct acylation of glycerol. J. Lipid Res. 42:2001;1970-1986.
107. Yen C.L., Farese R.V. Jr. MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine. J. Biol. Chem. 278:2003;18532-18537.
108. Cheng D., Nelson T.C., Chen J., Walker S.G., Wardwell-Swanson J., Meegalla R., Taub R., Billheimer J.T., Ramaker M., Feder J.N. Identification of acyl coenzyme A: monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption. J. Biol. Chem. 278:2003;13611- 13614.
109. Yen C.L., Stone S.J., Cases S., Zhou P., Farese R.V. Jr. Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8512-8517.
110. Trach V., Buschmans-Denkel E., Schaper W. Relation between lipolysis and glycolysis during ischemia in the isolated rat heart. Basic Res. Cardiol. 81:1986;454-464.
111. Robinson J., Newsholme E.A. Glycerol kinase activities in rat heart and adipose tissue. Biochem. J. 104:1967;2C-4C.
112. Scheuer J., Olson R.E. Metabolism of exogenous triglyceride by the isolated perfused rat heart. Am. J. Physiol. 212:1967;301-307.
113. Tamboli A., Vander Maten M., O'Looney P., Vahouny G.V. Metabolism of fatty acid, glycerol and a monoglyceride analogue by rat cardiac myocytes and perfused hearts. Lipids. 18:1983;808-813.
114. Severson D.L., Hurley B. Regulation of rat heart triacylglycerol ester hydrolases by free fatty acyl-CoA and fatty acylcarnitine. J. Mol. Cell. Cardiol. 14:1982;467-474.
115. Kohn M.C., Garfinkel D. Computer simulation of metabolism in palmitate-perfused rat heart I: palmitate oxidation. Ann. Biomed. Eng. 11:1984;361-384.
116. Stam H., Hulsmann W.C. Regulation of lipases involved in the supply of substrate fatty acids for the heart. Eur. Heart J. 6:1985;158-167.
117. McDonough K.H., Neely J.R. Inhibition of myocardial lipase by palmitolyl-CoA. J. Mol. Cell. Cardiol. 20(suppl. II):1988;31-39.
118. Stam H., Broekhoven-Schokker S., Hulsmann W.C. Characterization of mono-, di- and triacylglycerol lipase activities in the isolated rat heart. Biochim. Biophys. Acta. 875:1986;76-86.
119. Christiansen K. Membrane-bounded lipid particles from beef heart acylglycerol synthesis. Biochim. Biophys. Acta. 380:1975;390-402.
120. Wang T.W., Menahan L.A., Lech J.J. Subcellular localization of marker enzymes, lipase and triglyceride in rat heart. J. Mol. Cell. Cardiol. 9:1977;25-38.
121. Stam H., Broekhoven-Schokker S., Hulsmann W.C. Studies on the involvement of lipolytic enzymes in endogenous lipolysis of the isolated rat heart. Biochim. Biophys. Acta. 875:1986;87-96.
122. Schoonderwoerd K., Broekhoven-Schokker S., Hulsmann W.C., Stam H. Involvement of lysosome-like particles in the metabolism of endogenous myocardial triglycerides during ischemia/reperfusion. Uptake and degradation of triglycerides by lysosomes isolated from rat heart. Basic Res. Cardiol. 85:1990;153-163.
123. Hulsmann W.C., Stam H. Intracellular origin of hormone-sensitive lipolysis in the rat. Biochem. Biophys. Res. Commun. 82:1978;53-59.
124. Hulsmann W.C., Stam H., Breeman W.A. Acid- and neutral lipases involved in endogenous lipolysis in small intestine and heart. Biochem. Biophys. Res. Commun. 102:1981;440-448.
125. Nakagawa H., Matsubara S., Kuriyama M., Yoshidome H., Fujiyama J., Yoshida H., Osame M. Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model of Wolman's disease. J. Lipid Res. 36:1995;2212-2218.
126. Anderson R., Sando G. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J. Biol. Chem. 266:1991;22479-22484.
127. Du H., Sheriff S., Bezerra J., Leonova T., Grabowski G.A. Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease. Mol. Genet. Metab. 64:1998;126-134.
128. Murthy V.K., Stiles M.R., Shipp J.C. Inhibition by adenosine triphosphate of heart microsomal neutral lipase activity. Lipids. 18:1983;408-411.
129. Small C.A., Garton A.J., Yeaman S.J. The presence and role of hormone-sensitive lipase in heart muscle. Biochem. J. 258:1989;67-72.
130. Palmer W.K., Kane K.A. Hormone-stimulated lipolysis in cardiac myocytes. Biochem. J. 216:1983;241-243.
131. Palmer W.K. Hormonal regulation of myocardial lipolysis. Med. Sci. Sports Exerc. 15:1983;331-335.
132. Palmer W.K., Caruso R.A., Oscai L.B. Protein kinase inhibitor blocks the activation of a myocardial triacylglycerol lipase. J. Mol. Cell. Cardiol. 19:1987;653-659.
133. Shen H., Balschi J.A., Pohost G.M., Wolkowicz P. 1H-MRS detected lipolysis in diabetic rat hearts requires neutral lipase. J. Cardiovasc. Magn. Reson. 3:2001;35-45.
134. Suzuki J., Shen W.J., Nelson B.D., Patel S., Veerkamp J.H., Selwood S.P., Murphy G.M. Jr., Reaven E., Kraemer F.B. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. Am. J. Physiol: Endocrinol. Metab. 281:2001;E857-E866.
135. Haemmerle G., Zimmermann R., Hayn M., Theussl C., Waeg G., Wagner E., Sattler W., Magin T.M., Wagner E.F., Zechner R. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem. 277:2002;4806-4815.
136. Nielsen L.B., Veniant M., Boren J., Raabe M., Wong J.S., Tam C., Flynn L., Vanni-Reyes T., Gunn M.D., Goldberg I.J., Hamilton R.L., Young S.G. Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation. 98:1998;13-16.